Organovo Holdings Tuesday has completed the sale of its FXR program, including lead asset FXR314, to Eli Lilly and Company (LLY).The transaction, finalized on March 25 ...
Organovo Holdings, Inc. (Nasdaq:ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback